Tech Company Financing Transactions
Spotlight Therapeutics Funding Round
On 12/1/2020, Spotlight Therapeutics raised $30 million in Series A funding from GV and private investors.
Transaction Overview
Company Name
Announced On
12/1/2020
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
GV (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
26118 Research Pl.
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Undisclosed
Website
Email Address
Overview
Despite the promise of permanence, the full therapeutic potential of CRISPR gene editing is hindered by current delivery methods. To address the multiple limitations of cell, viral- and nanoparticle-mediated delivery for gene editing, we are developing a new class of biologics called Targeted Active Gene Editors (TAGE).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mary Haak-Frendscho
Vice President
Mary Janatpour
Vice President
Hari Jayaram
Browse more venture capital transactions:
Prev: 12/1/2020: Salut venture capital transaction
Next: 12/2/2020: Scale AI venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs